Cronus Pharma Introduces Pimobendan Chewable Tablets (First FDA-Approved Generic) for Veterinary Use

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Cronus Pharma LLC, a leader in animal health innovation, is excited to announce the release of its new Pimobendan Chewable Tablets, available for purchase in the U.S. veterinary market after June 9, 2026. This product is designed to support veterinarians in providing high-quality cardiac care for dogs. It is the first FDA-approved bioequivalent of Vetmedin®. About Pimobendan Chewable Tablets Indicated for the management of mild, moderate, or severe congest